SGCA
ALXN
Steel Grove Capital Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-8,650
| Closed | -$842K | – | 301 |
|
|
2018
Q4 | $842K | Sell |
8,650
-597
| -6% | -$58.1K | 0.12% | 152 |
|
|
2018
Q3 | $1.29M | Hold |
9,247
| – | – | 0.18% | 110 |
|
|
2018
Q2 | $1.15M | Hold |
9,247
| – | – | 0.18% | 113 |
|
|
2018
Q1 | $1.03M | Buy |
9,247
+5,762
| +165% | +$642K | 0.16% | 128 |
|
|
2017
Q4 | $417K | Hold |
3,485
| – | – | 0.06% | 216 |
|
|
2017
Q3 | $489K | Buy |
+3,485
| New | +$489K | 0.09% | 169 |
|